Ignite Creation Date:
2024-06-16 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06422624
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-22
First Post:
2024-05-15
Brief Title:
A Study to Evaluate Safety Tolerability and pK of Semaglutide ER Injectable Suspension in Healthy Adult Human Subjects
Sponsor:
Bostal Drug Delivery Co Ltd
Organization:
Bostal Drug Delivery Co Ltd
Study Overview
Official Title:
An Open Label Single Dose Dose Escalation Study to Evaluate Safety Tolerability and Pharmacokinetics of Semaglutide Extended-release Injectable Suspension in Normal Healthy Adult Human Study Participants Under Fasting Condition
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the trail is to evaluate the safety tolerability and pharmacokinetics of a single escalated doses of semaglutide extended-release injectable suspension in healthy adult human study participants under fasting condition
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None